Table 3

- Strength and certainty of evidence for the recommendations on the preventive therapy and complementary and alternative medicine.

RecommendationStrength of recommendationCertainty of evidencePercentage of panel agreement
14. For the prevention of episodic or chronic migraine, we recommend using propranolol over no treatment.StrongModerate100%
15. For the prevention of episodic or chronic migraine, we recommend using topiramate over no treatment.StrongModerate100%
16. For the prevention of episodic or chronic migraine, we suggest using propranolol over topiramate.ConditionalLow100%
17. For the prevention of episodic or chronic migraine, we suggest using valproate over no treatment.ConditionalVery low100%
18. For the prevention of episodic or chronic migraine, we suggest using erenumab over no treatment.ConditionalModerate82%
19. For the prevention of episodic or chronic migraine, we suggest using fremanezumab over no treatment.ConditionalModerate91%
20. For the prevention of episodic or chronic migraine, we suggest using galcanezumab over no treatment.ConditionalModerate82%
21. For the prevention of episodic or chronic migraine, we suggest using eptinezumab over no treatment.ConditionalModerate82%
22. For the prevention of chronic migraine, we suggest using botulinum toxin over no treatment.ConditionalVery low100%
23. For the prevention of chronic migraine, we suggest using greater occipital nerve block over no treatmentConditionalVery low91%
24. For the prevention of episodic or chronic migraine, we suggest using atogepant over no treatment.ConditionalLow100%
25. For the prevention of episodic or chronic migraine, we recommend using amitriptyline over no treatment (strong recommendation, low certainty of evidence).StrongLow100%
26. For patient with low serum vitamin D level and chronic migraine, we suggest using vitamin D replacement over no treatment.ConditionalLow82%